nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—CYP3A4—bone cancer	0.459	1	CbGaD
Podofilox—TOP2A—Epirubicin—bone cancer	0.247	0.635	CbGbCtD
Podofilox—TOP2A—Doxorubicin—bone cancer	0.131	0.338	CbGbCtD
Podofilox—CYP3A4—Doxorubicin—bone cancer	0.0105	0.0271	CbGbCtD
Podofilox—TOP2A—Gastric Cancer Network 1—C21orf33—bone cancer	0.00635	0.0459	CbGpPWpGaD
Podofilox—TUBA4A—Post-chaperonin tubulin folding pathway—TUBB4B—bone cancer	0.00622	0.045	CbGpPWpGaD
Podofilox—TUBA4A—Formation of tubulin folding intermediates by CCT/TriC—TUBB4B—bone cancer	0.00574	0.0415	CbGpPWpGaD
Podofilox—TUBA4A—Post-chaperonin tubulin folding pathway—TUBB2A—bone cancer	0.00537	0.0388	CbGpPWpGaD
Podofilox—TUBA4A—Formation of tubulin folding intermediates by CCT/TriC—TUBB2A—bone cancer	0.00495	0.0358	CbGpPWpGaD
Podofilox—TUBA4A—Prefoldin mediated transfer of substrate to CCT/TriC—TUBB4B—bone cancer	0.00469	0.0339	CbGpPWpGaD
Podofilox—TUBA4A—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBB4B—bone cancer	0.00456	0.033	CbGpPWpGaD
Podofilox—TUBA4A—Prefoldin mediated transfer of substrate to CCT/TriC—TUBB2A—bone cancer	0.00405	0.0293	CbGpPWpGaD
Podofilox—TUBA4A—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBB2A—bone cancer	0.00393	0.0285	CbGpPWpGaD
Podofilox—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—T—bone cancer	0.00367	0.0265	CbGpPWpGaD
Podofilox—Etoposide—GSTP1—bone cancer	0.00314	0.482	CrCbGaD
Podofilox—TUBA4A—Chaperonin-mediated protein folding—TUBB4B—bone cancer	0.00291	0.0211	CbGpPWpGaD
Podofilox—TUBA4A—Pathogenic Escherichia coli infection—TUBB4B—bone cancer	0.00266	0.0192	CbGpPWpGaD
Podofilox—TUBA4A—Protein folding—TUBB4B—bone cancer	0.00266	0.0192	CbGpPWpGaD
Podofilox—TUBA4A—Chaperonin-mediated protein folding—TUBB2A—bone cancer	0.00251	0.0182	CbGpPWpGaD
Podofilox—TUBA4A—Loss of Nlp from mitotic centrosomes—TUBB4B—bone cancer	0.00244	0.0177	CbGpPWpGaD
Podofilox—NR3C1—Signaling events mediated by HDAC Class II—BCOR—bone cancer	0.00238	0.0172	CbGpPWpGaD
Podofilox—TUBA4A—Pathogenic Escherichia coli infection—TUBB2A—bone cancer	0.00229	0.0166	CbGpPWpGaD
Podofilox—TUBA4A—Protein folding—TUBB2A—bone cancer	0.00229	0.0166	CbGpPWpGaD
Podofilox—TUBB—Pathogenic Escherichia coli infection—TUBB4B—bone cancer	0.00226	0.0163	CbGpPWpGaD
Podofilox—TUBA4A—Parkin-Ubiquitin Proteasomal System pathway—TUBB4B—bone cancer	0.00219	0.0158	CbGpPWpGaD
Podofilox—TUBA4A—Centrosome maturation—TUBB4B—bone cancer	0.00217	0.0157	CbGpPWpGaD
Podofilox—TUBB—Loss of Nlp from mitotic centrosomes—TUBB4B—bone cancer	0.00208	0.015	CbGpPWpGaD
Podofilox—TUBA4A—Regulation of PLK1 Activity at G2/M Transition—TUBB4B—bone cancer	0.00199	0.0144	CbGpPWpGaD
Podofilox—TUBB—Pathogenic Escherichia coli infection—TUBB2A—bone cancer	0.00195	0.0141	CbGpPWpGaD
Podofilox—TUBA4A—Parkin-Ubiquitin Proteasomal System pathway—TUBB2A—bone cancer	0.00189	0.0137	CbGpPWpGaD
Podofilox—TUBB—Parkin-Ubiquitin Proteasomal System pathway—TUBB4B—bone cancer	0.00186	0.0135	CbGpPWpGaD
Podofilox—TUBB—Centrosome maturation—TUBB4B—bone cancer	0.00184	0.0133	CbGpPWpGaD
Podofilox—TUBB—Regulation of PLK1 Activity at G2/M Transition—TUBB4B—bone cancer	0.00169	0.0122	CbGpPWpGaD
Podofilox—TUBB—Parkin-Ubiquitin Proteasomal System pathway—TUBB2A—bone cancer	0.00161	0.0116	CbGpPWpGaD
Podofilox—TUBA4A—G2/M Transition—TUBB4B—bone cancer	0.00149	0.0108	CbGpPWpGaD
Podofilox—TUBA4A—Mitotic G2-G2/M phases—TUBB4B—bone cancer	0.00147	0.0106	CbGpPWpGaD
Podofilox—Teniposide—CYP3A4—bone cancer	0.00137	0.21	CrCbGaD
Podofilox—TUBB—G2/M Transition—TUBB4B—bone cancer	0.00127	0.00918	CbGpPWpGaD
Podofilox—TUBB—Mitotic G2-G2/M phases—TUBB4B—bone cancer	0.00125	0.00905	CbGpPWpGaD
Podofilox—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00118	0.00854	CbGpPWpGaD
Podofilox—TUBA4A—Platelet degranulation—SPARC—bone cancer	0.00113	0.00817	CbGpPWpGaD
Podofilox—NR3C1—Signaling events mediated by HDAC Class II—TUBB2A—bone cancer	0.00112	0.00812	CbGpPWpGaD
Podofilox—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—ATF1—bone cancer	0.00111	0.008	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.00108	0.00779	CbGpPWpGaD
Podofilox—NR3C1—Nuclear Receptors—NR1I2—bone cancer	0.00106	0.00767	CbGpPWpGaD
Podofilox—Etoposide—CYP3A4—bone cancer	0.00101	0.156	CrCbGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—FEV—bone cancer	0.00101	0.00732	CbGpPWpGaD
Podofilox—Etoposide—PTGS2—bone cancer	0.000992	0.152	CrCbGaD
Podofilox—TOP2A—Circadian rythm related genes—TNFRSF11A—bone cancer	0.000869	0.00629	CbGpPWpGaD
Podofilox—NR3C1—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.000838	0.00606	CbGpPWpGaD
Podofilox—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—bone cancer	0.000713	0.00516	CbGpPWpGaD
Podofilox—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00071	0.00514	CbGpPWpGaD
Podofilox—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000668	0.00483	CbGpPWpGaD
Podofilox—TOP2A—Doxorubicin—Epirubicin—bone cancer	0.00066	0.173	CbGdCrCtD
Podofilox—TOP2A—Daunorubicin—Epirubicin—bone cancer	0.00066	0.173	CbGdCrCtD
Podofilox—TOP2A—Idarubicin—Epirubicin—bone cancer	0.00066	0.173	CbGdCrCtD
Podofilox—TUBA4A—Metabolism of proteins—MOGS—bone cancer	0.000646	0.00467	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—ZW10—bone cancer	0.000627	0.00453	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—DHFR—bone cancer	0.000615	0.00445	CbGpPWpGaD
Podofilox—TOP2A—Epirubicin—Doxorubicin—bone cancer	0.00061	0.16	CbGdCrCtD
Podofilox—TOP2A—Idarubicin—Doxorubicin—bone cancer	0.00061	0.16	CbGdCrCtD
Podofilox—TOP2A—Daunorubicin—Doxorubicin—bone cancer	0.00061	0.16	CbGdCrCtD
Podofilox—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—bone cancer	0.000592	0.00428	CbGpPWpGaD
Podofilox—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.00057	0.00412	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—ZW10—bone cancer	0.00056	0.00405	CbGpPWpGaD
Podofilox—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.000548	0.00396	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—ZW10—bone cancer	0.000533	0.00385	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000508	0.00368	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.000501	0.00363	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—ZW10—bone cancer	0.000476	0.00345	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.000475	0.00343	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.000459	0.00332	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—DHFR—bone cancer	0.000433	0.00313	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—RFC1—bone cancer	0.000431	0.00311	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—ZNF77—bone cancer	0.000428	0.00309	CbGpPWpGaD
Podofilox—NR3C1—Endoderm Differentiation—EZH2—bone cancer	0.000427	0.00309	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TUBB4B—bone cancer	0.000425	0.00307	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—IL3—bone cancer	0.000416	0.00301	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.000404	0.00292	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000394	0.00285	CbGpPWpGaD
Podofilox—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—bone cancer	0.000392	0.00284	CbGpPWpGaD
Podofilox—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000391	0.00283	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—RFC1—bone cancer	0.000385	0.00278	CbGpPWpGaD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000384	0.00278	CbGpPWpGaD
Podofilox—TOP2A—Gastric Cancer Network 2—EGFR—bone cancer	0.000374	0.0027	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—ZW10—bone cancer	0.000373	0.0027	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—RFC1—bone cancer	0.000366	0.00265	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TUBB4B—bone cancer	0.000361	0.00261	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—TUBB4B—bone cancer	0.000354	0.00256	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000335	0.00242	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—ZW10—bone cancer	0.000333	0.00241	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—RFC1—bone cancer	0.000327	0.00237	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—bone cancer	0.000323	0.00234	CbGpPWpGaD
Podofilox—TOP2A—Gastric Cancer Network 2—TP53—bone cancer	0.000314	0.00227	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000306	0.00221	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—TUBB2A—bone cancer	0.000306	0.00221	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000305	0.00221	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—GNA11—bone cancer	0.000294	0.00213	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—EZH2—bone cancer	0.000293	0.00212	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.000282	0.00204	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—RB1—bone cancer	0.000281	0.00203	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000278	0.00201	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000274	0.00198	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—DHFR—bone cancer	0.000267	0.00193	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—SPARC—bone cancer	0.000258	0.00187	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—RFC1—bone cancer	0.000256	0.00185	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TUBB4B—bone cancer	0.000253	0.00183	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—PLAU—bone cancer	0.000249	0.0018	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—bone cancer	0.00024	0.00173	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—DHFR—bone cancer	0.000239	0.00173	CbGpPWpGaD
Podofilox—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000237	0.00171	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—GNA11—bone cancer	0.000236	0.00171	CbGpPWpGaD
Podofilox—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000234	0.00169	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000232	0.00168	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—RFC1—bone cancer	0.000229	0.00166	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—CDK4—bone cancer	0.000227	0.00164	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—DHFR—bone cancer	0.000227	0.00164	CbGpPWpGaD
Podofilox—NR3C1—Regulation of Androgen receptor activity—MDM2—bone cancer	0.000218	0.00158	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—IL3—bone cancer	0.000214	0.00155	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—EIF2S1—bone cancer	0.000213	0.00154	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	0.00021	0.00152	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—ZNF77—bone cancer	0.000206	0.00149	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—DHFR—bone cancer	0.000203	0.00147	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CHEK2—bone cancer	0.0002	0.00144	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—RB1—bone cancer	0.000198	0.00143	CbGpPWpGaD
Podofilox—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000192	0.00139	CbGpPWpGaD
Podofilox—NR3C1—Regulation of Androgen receptor activity—JUN—bone cancer	0.00019	0.00137	CbGpPWpGaD
Podofilox—Tenderness—Cisplatin—bone cancer	0.00018	0.0381	CcSEcCtD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000172	0.00125	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CHEK2—bone cancer	0.00017	0.00123	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—BRCA2—bone cancer	0.000169	0.00122	CbGpPWpGaD
Podofilox—Ulcer—Cisplatin—bone cancer	0.000166	0.0352	CcSEcCtD
Podofilox—TOP2A—Circadian rythm related genes—CDK4—bone cancer	0.000165	0.0012	CbGpPWpGaD
Podofilox—Pain—Carboplatin—bone cancer	0.000163	0.0346	CcSEcCtD
Podofilox—TOP2A—Cell Cycle, Mitotic—DHFR—bone cancer	0.000159	0.00115	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—MDM2—bone cancer	0.000154	0.00111	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—JUN—bone cancer	0.000152	0.0011	CbGpPWpGaD
Podofilox—Skin exfoliation—Cisplatin—bone cancer	0.00015	0.0318	CcSEcCtD
Podofilox—NR3C1—AP-1 transcription factor network—MMP9—bone cancer	0.000148	0.00107	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—NR1I2—bone cancer	0.000145	0.00105	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—BRCA2—bone cancer	0.000144	0.00104	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—DHFR—bone cancer	0.000142	0.00103	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—PLAU—bone cancer	0.000141	0.00102	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CDK4—bone cancer	0.00014	0.00101	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—TP53—bone cancer	0.000137	0.000994	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	0.000135	0.000977	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—JUN—bone cancer	0.000134	0.000968	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000128	0.000924	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CDK4—bone cancer	0.000125	0.000907	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—RB1—bone cancer	0.000125	0.000903	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000123	0.00089	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—RB1—bone cancer	0.000122	0.000882	CbGpPWpGaD
Podofilox—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	0.000121	0.000878	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CDK4—bone cancer	0.000119	0.000862	CbGpPWpGaD
Podofilox—Redness—Epirubicin—bone cancer	0.000119	0.0253	CcSEcCtD
Podofilox—TOP2A—Cell Cycle—CHEK2—bone cancer	0.000119	0.000858	CbGpPWpGaD
Podofilox—Blister—Epirubicin—bone cancer	0.000112	0.0237	CcSEcCtD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000111	0.000803	CbGpPWpGaD
Podofilox—Skin ulcer—Methotrexate—bone cancer	0.00011	0.0234	CcSEcCtD
Podofilox—Redness—Doxorubicin—bone cancer	0.00011	0.0234	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle—RB1—bone cancer	0.000109	0.000788	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CDK4—bone cancer	0.000107	0.000771	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—JUN—bone cancer	0.000107	0.000771	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—RB1—bone cancer	0.000104	0.00075	CbGpPWpGaD
Podofilox—Skin ulcer—Epirubicin—bone cancer	0.000103	0.0219	CcSEcCtD
Podofilox—Blister—Doxorubicin—bone cancer	0.000103	0.0219	CcSEcCtD
Podofilox—CYP2C19—Biological oxidations—CYP3A4—bone cancer	0.000102	0.000737	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—FUS—bone cancer	0.000101	0.000727	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—BRCA2—bone cancer	0.000101	0.000727	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	0.000101	0.000727	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TP53—bone cancer	0.0001	0.000725	CbGpPWpGaD
Podofilox—Stinging—Epirubicin—bone cancer	9.93e-05	0.0211	CcSEcCtD
Podofilox—Skin ulcer—Doxorubicin—bone cancer	9.56e-05	0.0203	CcSEcCtD
Podofilox—Skin discolouration—Methotrexate—bone cancer	9.52e-05	0.0202	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle—MDM2—bone cancer	9.3e-05	0.000672	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—RB1—bone cancer	9.27e-05	0.00067	CbGpPWpGaD
Podofilox—Stinging—Doxorubicin—bone cancer	9.19e-05	0.0195	CcSEcCtD
Podofilox—Ulcer—Methotrexate—bone cancer	9.09e-05	0.0193	CcSEcCtD
Podofilox—Skin discolouration—Epirubicin—bone cancer	8.91e-05	0.0189	CcSEcCtD
Podofilox—Inflammation—Methotrexate—bone cancer	8.86e-05	0.0188	CcSEcCtD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—TP53—bone cancer	8.83e-05	0.000639	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	8.73e-05	0.000631	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—GSTP1—bone cancer	8.72e-05	0.00063	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—MMP2—bone cancer	8.72e-05	0.00063	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	8.6e-05	0.000622	CbGpPWpGaD
Podofilox—Ulcer—Epirubicin—bone cancer	8.51e-05	0.0181	CcSEcCtD
Podofilox—TOP2A—Cell Cycle, Mitotic—CDK4—bone cancer	8.34e-05	0.000603	CbGpPWpGaD
Podofilox—Inflammation—Epirubicin—bone cancer	8.29e-05	0.0176	CcSEcCtD
Podofilox—Skin discolouration—Doxorubicin—bone cancer	8.24e-05	0.0175	CcSEcCtD
Podofilox—Skin exfoliation—Methotrexate—bone cancer	8.21e-05	0.0174	CcSEcCtD
Podofilox—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	8.09e-05	0.000585	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—JUN—bone cancer	8e-05	0.000578	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MDM2—bone cancer	7.9e-05	0.000572	CbGpPWpGaD
Podofilox—Ulcer—Doxorubicin—bone cancer	7.87e-05	0.0167	CcSEcCtD
Podofilox—Skin exfoliation—Epirubicin—bone cancer	7.68e-05	0.0163	CcSEcCtD
Podofilox—Inflammation—Doxorubicin—bone cancer	7.67e-05	0.0163	CcSEcCtD
Podofilox—TOP2A—Cell Cycle—CDK4—bone cancer	7.46e-05	0.000539	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	7.33e-05	0.00053	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—RB1—bone cancer	7.25e-05	0.000524	CbGpPWpGaD
Podofilox—Skin exfoliation—Doxorubicin—bone cancer	7.11e-05	0.0151	CcSEcCtD
Podofilox—Immune system disorder—Cisplatin—bone cancer	7.11e-05	0.0151	CcSEcCtD
Podofilox—TOP2A—Circadian rythm related genes—TP53—bone cancer	7.03e-05	0.000509	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—NR1I2—bone cancer	6.97e-05	0.000504	CbGpPWpGaD
Podofilox—Erythema—Cisplatin—bone cancer	6.85e-05	0.0145	CcSEcCtD
Podofilox—TOP2A—Cell Cycle—RB1—bone cancer	6.48e-05	0.000469	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NDUFA12—bone cancer	6.11e-05	0.000442	CbGpPWpGaD
Podofilox—Dermatitis bullous—Epirubicin—bone cancer	6.11e-05	0.013	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	5.79e-05	0.0123	CcSEcCtD
Podofilox—Dermatitis bullous—Doxorubicin—bone cancer	5.65e-05	0.012	CcSEcCtD
Podofilox—TUBA4A—Hemostasis—TP53—bone cancer	5.65e-05	0.000409	CbGpPWpGaD
Podofilox—Oedema—Cisplatin—bone cancer	5.59e-05	0.0119	CcSEcCtD
Podofilox—TOP2A—Cell Cycle—MDM2—bone cancer	5.53e-05	0.0004	CbGpPWpGaD
Podofilox—Skin disorder—Cisplatin—bone cancer	5.43e-05	0.0115	CcSEcCtD
Podofilox—Dry skin—Epirubicin—bone cancer	5.35e-05	0.0114	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle—TP53—bone cancer	5.33e-05	0.000386	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.24e-05	0.000379	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5.17e-05	0.000374	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—EIF2S1—bone cancer	5.15e-05	0.000372	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—NT5C3A—bone cancer	5.06e-05	0.000366	CbGpPWpGaD
Podofilox—Paraesthesia—Cisplatin—bone cancer	5.02e-05	0.0107	CcSEcCtD
Podofilox—Dry skin—Doxorubicin—bone cancer	4.95e-05	0.0105	CcSEcCtD
Podofilox—Pain—Cisplatin—bone cancer	4.78e-05	0.0101	CcSEcCtD
Podofilox—Haematuria—Methotrexate—bone cancer	4.58e-05	0.00973	CcSEcCtD
Podofilox—TUBB—Cell Cycle—TP53—bone cancer	4.54e-05	0.000328	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—EZH2—bone cancer	4.47e-05	0.000323	CbGpPWpGaD
Podofilox—Haemoglobin—Methotrexate—bone cancer	4.34e-05	0.00921	CcSEcCtD
Podofilox—Haemorrhage—Methotrexate—bone cancer	4.32e-05	0.00916	CcSEcCtD
Podofilox—Haematuria—Epirubicin—bone cancer	4.29e-05	0.00911	CcSEcCtD
Podofilox—Haemoglobin—Epirubicin—bone cancer	4.06e-05	0.00862	CcSEcCtD
Podofilox—Haemorrhage—Epirubicin—bone cancer	4.04e-05	0.00858	CcSEcCtD
Podofilox—Haematuria—Doxorubicin—bone cancer	3.97e-05	0.00843	CcSEcCtD
Podofilox—Immune system disorder—Methotrexate—bone cancer	3.9e-05	0.00828	CcSEcCtD
Podofilox—Erythema—Methotrexate—bone cancer	3.76e-05	0.00798	CcSEcCtD
Podofilox—Haemoglobin—Doxorubicin—bone cancer	3.76e-05	0.00798	CcSEcCtD
Podofilox—Haemorrhage—Doxorubicin—bone cancer	3.74e-05	0.00794	CcSEcCtD
Podofilox—CYP3A4—Metabolism—NDUFA12—bone cancer	3.67e-05	0.000266	CbGpPWpGaD
Podofilox—Immune system disorder—Epirubicin—bone cancer	3.65e-05	0.00775	CcSEcCtD
Podofilox—Vomiting—Cisplatin—bone cancer	3.55e-05	0.00754	CcSEcCtD
Podofilox—Rash—Cisplatin—bone cancer	3.52e-05	0.00748	CcSEcCtD
Podofilox—Dermatitis—Cisplatin—bone cancer	3.52e-05	0.00747	CcSEcCtD
Podofilox—Erythema—Epirubicin—bone cancer	3.52e-05	0.00747	CcSEcCtD
Podofilox—Immune system disorder—Doxorubicin—bone cancer	3.38e-05	0.00717	CcSEcCtD
Podofilox—Erythema—Doxorubicin—bone cancer	3.25e-05	0.00691	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	3.18e-05	0.00675	CcSEcCtD
Podofilox—TOP2A—Cell Cycle—TP53—bone cancer	3.17e-05	0.000229	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—NT5C3A—bone cancer	3.04e-05	0.00022	CbGpPWpGaD
Podofilox—Skin disorder—Methotrexate—bone cancer	2.98e-05	0.00632	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	2.97e-05	0.00631	CcSEcCtD
Podofilox—Oedema—Epirubicin—bone cancer	2.87e-05	0.00609	CcSEcCtD
Podofilox—Skin disorder—Epirubicin—bone cancer	2.79e-05	0.00592	CcSEcCtD
Podofilox—Insomnia—Methotrexate—bone cancer	2.77e-05	0.00589	CcSEcCtD
Podofilox—Paraesthesia—Methotrexate—bone cancer	2.75e-05	0.00585	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	2.75e-05	0.00584	CcSEcCtD
Podofilox—Oedema—Doxorubicin—bone cancer	2.66e-05	0.00564	CcSEcCtD
Podofilox—Pain—Methotrexate—bone cancer	2.62e-05	0.00557	CcSEcCtD
Podofilox—Insomnia—Epirubicin—bone cancer	2.6e-05	0.00551	CcSEcCtD
Podofilox—Skin disorder—Doxorubicin—bone cancer	2.58e-05	0.00548	CcSEcCtD
Podofilox—Paraesthesia—Epirubicin—bone cancer	2.58e-05	0.00547	CcSEcCtD
Podofilox—Pain—Epirubicin—bone cancer	2.45e-05	0.00521	CcSEcCtD
Podofilox—Insomnia—Doxorubicin—bone cancer	2.4e-05	0.0051	CcSEcCtD
Podofilox—Paraesthesia—Doxorubicin—bone cancer	2.38e-05	0.00506	CcSEcCtD
Podofilox—Pain—Doxorubicin—bone cancer	2.27e-05	0.00482	CcSEcCtD
Podofilox—CYP2C19—Metabolism—ENO2—bone cancer	2.22e-05	0.00016	CbGpPWpGaD
Podofilox—Pruritus—Methotrexate—bone cancer	2.17e-05	0.00461	CcSEcCtD
Podofilox—CYP2C19—Metabolism—DHFR—bone cancer	2.06e-05	0.000149	CbGpPWpGaD
Podofilox—Pruritus—Epirubicin—bone cancer	2.03e-05	0.00431	CcSEcCtD
Podofilox—Dizziness—Methotrexate—bone cancer	2.03e-05	0.00431	CcSEcCtD
Podofilox—Vomiting—Methotrexate—bone cancer	1.95e-05	0.00414	CcSEcCtD
Podofilox—Rash—Methotrexate—bone cancer	1.93e-05	0.00411	CcSEcCtD
Podofilox—Dermatitis—Methotrexate—bone cancer	1.93e-05	0.0041	CcSEcCtD
Podofilox—CYP2C19—Metabolism—GNA11—bone cancer	1.92e-05	0.000139	CbGpPWpGaD
Podofilox—Headache—Methotrexate—bone cancer	1.92e-05	0.00408	CcSEcCtD
Podofilox—Dizziness—Epirubicin—bone cancer	1.9e-05	0.00403	CcSEcCtD
Podofilox—Pruritus—Doxorubicin—bone cancer	1.88e-05	0.00399	CcSEcCtD
Podofilox—Vomiting—Epirubicin—bone cancer	1.82e-05	0.00387	CcSEcCtD
Podofilox—Rash—Epirubicin—bone cancer	1.81e-05	0.00384	CcSEcCtD
Podofilox—Dermatitis—Epirubicin—bone cancer	1.81e-05	0.00384	CcSEcCtD
Podofilox—Headache—Epirubicin—bone cancer	1.8e-05	0.00382	CcSEcCtD
Podofilox—Dizziness—Doxorubicin—bone cancer	1.76e-05	0.00373	CcSEcCtD
Podofilox—CYP2C19—Metabolism—CYP3A4—bone cancer	1.74e-05	0.000126	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.73e-05	0.000125	CbGpPWpGaD
Podofilox—Vomiting—Doxorubicin—bone cancer	1.69e-05	0.00358	CcSEcCtD
Podofilox—Rash—Doxorubicin—bone cancer	1.67e-05	0.00355	CcSEcCtD
Podofilox—Dermatitis—Doxorubicin—bone cancer	1.67e-05	0.00355	CcSEcCtD
Podofilox—Headache—Doxorubicin—bone cancer	1.66e-05	0.00353	CcSEcCtD
Podofilox—CYP2C19—Metabolism—GSTP1—bone cancer	1.49e-05	0.000108	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ENO2—bone cancer	1.33e-05	9.64e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—DHFR—bone cancer	1.24e-05	8.95e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GNA11—bone cancer	1.16e-05	8.36e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GSTP1—bone cancer	8.97e-06	6.48e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PTGS2—bone cancer	7.72e-06	5.59e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PTGS2—bone cancer	4.64e-06	3.36e-05	CbGpPWpGaD
